97-22089. Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 62, Number 161 (Wednesday, August 20, 1997)]
    [Notices]
    [Page 44283]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-22089]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). The meeting will 
    be open to the public.
        Name of Committee: Circulatory System Devices Panel of the Medical 
    Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on September 15, 1997, 9:30 
    a.m. to 6 p.m., and September 16, 1997, 8:30 a.m. to 3 p.m.
        Location: Gaithersburg Hilton, Salons A, B, and C of the Ballroom, 
    620 Perry Pkwy., Gaithersburg, MD.
        Contact Person: John E. Stuhlmuller, Center for Devices and 
    Radiological Health (HFZ-450), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-443-8243, ext. 157, or FDA 
    Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in 
    the Washington, DC area), code 12625. Please call the Information Line 
    for up-to-date information on this meeting.
        Agenda: On September 15, 1997, the committee will hear a 
    presentation of the basic concepts of FDA's Product Development 
    Process. The committee will discuss and make recommendations on two 
    premarket approval (PMA) applications for prosthetic heart valves. On 
    September 16, 1997, the committee will discuss and make recommendations 
    on a PMA for a prosthetic heart valve.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by September 5, 
    1997. Oral presentations from the public will be scheduled between 
    approximately 9:30 a.m. and 10:30 a.m. on September 15, 1997, and 
    between approximately 8:30 a.m. and 9:30 a.m. on September 16, 1997. 
    Time allotted for each presentation may be limited. Those desiring to 
    make formal oral presentations should notify the contact person before 
    September 5, 1997, and submit a brief statement of the general nature 
    of the evidence or arguments they wish to present, the names and 
    addresses of proposed participants, and an indication of the 
    approximate time requested to make their presentation.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C. app. 2).
    
        Dated: August 14, 1997.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 97-22089 Filed 8-19-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/20/1997
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
97-22089
Pages:
44283-44283 (1 pages)
PDF File:
97-22089.pdf